The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators.
With 8 tracks of content, the agenda covers everything from manufacturing, supply chain & logistics, pricing & market access, to developments in key therapeutic areas. This includes cell therapy, gene therapy, gene modified cell therapy, gene editing, stem cells and regenerative medicine, and much more.
At a time of great uncertainty for biotech, and for the world itself, the leaders of biotech, pharma, fast-growing industry start-ups and established solution providers will be gathered together to give us a good indication of where cell and gene therapy is heading next.
RIBOPRO will be present to answer any questions you may have regarding mRNA. We hope to see you there!
